About us
Our Company
Our Leadership
Precision Research
GPCRs in IO
Our innovative approach
Our Programs
Partnerships
Our Collaborations
Our Partners
News & Media
Press releases
News
Downloads
Opportunities
Partnering Opportunities
Career opportunities
Search on our website
Type Enter to start searching.
Pipeline
Scroll to explore
Latest
Scroll back top
23 October 2024
Prix Galien USA: Domain Therapeutics Nominated for the Prestigious Best Startup Award
Discover more
6 June 2024
Domain Therapeutics strengthens its intellectual property for its series of Treg depleting anti-CCR...
Discover more
17 April 2024
Domain Therapeutics appoints Sean A. MacDonald as Chief Executive Officer
Discover more
2 April 2024
Domain Therapeutics to participate at premier investor and healthcare conferences
Discover more
26 March 2024
Domain Therapeutics to present latest data on DT-9045, a first-in-class Negative Allosteric Modulat...
Discover more
12 March 2024
Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 ...
Discover more
8 March 2024
indice d’égalité femmes-hommes 2024
Discover more
27 February 2024
Domain Therapeutics promotes Stephan Schann as Chief Scientific Officer (CSO)
Discover more
8 February 2024
Domain Therapeutics further strengthens leadership team with appointment of Sean A. MacDonald as Ch...
Discover more
25 January 2024
Domain Therapeutics awarded Hospital-University Research in Health (RHU) SPRINT consortium grant to ...
Discover more
